Byrd, J. C. Et Al. 2021. First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21 .

Byrd, J. C., Hillmen, P., Ghia, P., Kater, A. P., Chanan-Khan, A., Furman, R. R., ... O'Brien, S.(2021). First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21.

Byrd, John Et Al. "First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, 2021

Byrd, John C. Et Al. "First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, 2021

Byrd, J. C. Et Al. (2021) . "First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21.

@article{article, author={John C. Byrd Et Al. }, title={First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia}, journal={CLINICAL LYMPHOMA MYELOMA & LEUKEMIA}, year=2021}